A structural perspective of the Flavivirus life cycle

Nature Reviews Microbiology

Volumn 3, Issue 1, 2005, Pages 13-22

  Mukhopadhyay, Suchetana ^a   Kuhn, Richard J ^a   Rossmann, Michael G ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; CD14 ANTIGEN; CD209 ANTIGEN; GLUCOSE REGULATED PROTEIN 78; GLUCOSIDE; GLYCOPROTEIN; M PROTEIN; MEMBRANE PROTEIN; NUCLEOCAPSID PROTEIN; STRUCTURAL PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS RNA;

ALPHA VIRUS; AMINO TERMINAL SEQUENCE; BINDING SITE; BUDDING; CARBOXY TERMINAL SEQUENCE; CORONAVIRUS; CRYOELECTRON MICROSCOPY; DENGUE; DENGUE VIRUS; EPIDEMIC; EPIDEMIC ENCEPHALITIS; FLAVIVIRUS; GENE FUSION; GENOME ANALYSIS; INCIDENCE; JAPANESE ENCEPHALITIS VIRUS; LIFE CYCLE; MORTALITY; NONHUMAN; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; RETROVIRUS; REVIEW; STRAIN DIFFERENCE; STRUCTURE ANALYSIS; SYMPTOMATOLOGY; VIRION; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS GENOME; VIRUS INFECTION; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS REPLICATION; X RAY CRYSTALLOGRAPHY; YELLOW FEVER;

CAPSID PROTEINS; FLAVIVIRUS; MEMBRANE FUSION; MODELS, MOLECULAR; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL ENVELOPE PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRION; VIRUS REPLICATION;

ALPHAVIRUS; CORONAVIRUS; DENGUE VIRUS; FLAVIVIRIDAE; FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS; PARAMYXOVIRIDAE; UNIDENTIFIED RETROVIRUS;

EID: 11144348130     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1067     Document Type: Review

References (94)

1. Kuno, G., Chang, G. J., Tsuchiya, K. R., Karabatsos, N. & Cropp, C. B. Phylogeny of the genus Flavivirus. J. Virol. 72, 73-83 (1998).
2. Lindenbach, B. D. & Rice, C. M. in Fields Virology (ads Knipe, D. M. & Howley, F. M.) 991-1041 (Lippincott Williams & Wilkins, Philadelphia, 2001).
3. Burke, D. S. & Monath, T. P. in Fields Virology (eds Knipe, D. M. & Howley, F. M.) 1043-1125 (Lippincott Williams & Wilkins, Philadelphia, 2001).
4. Gubler, D. J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 10, 100-103 (2002).
5. WHO. Dengue factsheet. [online], (2002).
6. CDC. Cases of West Nile human disease. [online], (2004).
7. WHO. Yellow fever factsheet. [online], (2001).
8. WHO. Immunization, vaccines and biologicals: Japanese encephalitis. [online], (2002).
9. Lorenz, I. C., Allison, S. L., Heinz, F. X. & Helenius, A. Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J. Virol. 76 5480-5491 (2002).
10. Stadler, K., Allison, S. L., Schalich, J. & Heinz, F. X. Proteolytic activation of tick-borne encephalitis virus by furin. J. Virol. 71, 8475-8481 (1997).
11. Allison, S. L., Schalich, J., Stiasny, K., Mandl, C. W. & Heinz, F. X. Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J. Virol. 75, 4268-4275 (2001).
12. Allison, S. L. et al. Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J. Virol. 69, 695-700 (1995).
13. Corver, J. et al. Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system. Virology 269, 37-46 (2000).
14. Lindenbach, B. D. & Rice, C. M. Molecular biology of flaviviruses. Adv. Virus Res. 59, 23-61 (2003).
15. Brinton, M. A. The molecular biology of West Nile virus: a new invader of the western hemisphere. Annu. Rev. Microbiol. 56 371-402 (2002).
16. Guirakhoo, F., Heinz, F. X., Mandl, C. W., Holzmann, H. & Kunz, C. Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J. Gen. Virol. 72, 1323-1329 (1991).
17. Guirakhoo, F., Bolin, R. A. & Roehrig, J. T. The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology 191, 921-931 (1992).
18. Elshuber, S., Allison, S. L., Heinz, F. X. & Mandl, C. W. Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus. J. Gen. Virol. 84, 183-191 (2003).
19. Schalich, J. et al. Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J. Virol. 70, 4549-4557 (1996).
20. Mancini, E. J., Clarke, M., Gowen, B. E., Rutten, T. & Fuller, S. D. Cryo-electron microscopy reveals the functional organization of an enveloped virus, Semliki Forest virus. Mol. Cell 5, 255-266 (2000).
21. Zhang, W. et al. Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nature Struct. Biol. 10, 907-912 (2003).
22. Zhang, W. et al. Placement of the structural proteins in Sindbis virus. J. Virol. 76, 11645-11658 (2002).
23. Ma, L., Jones, C. T., Groesch, T. D., Kuhn, R. J. & Post, C. B. Solution structure of dengue virus capsid protein reveals another fold. Proc. Natl Acad. Sci. USA 101, 3414-3419 (2004).
24. Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl Acad. Sci. USA 100, 6986-6991 (2003).
25. Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C. & Harrison, S. C. The envelope glycoprotein from tick-borne encephalitis virus at 2-Å resolution. Nature 375, 291-298 (1995).
26. Zhang, Y. et al. Conformational changes of the flavivirus E glycoprotein. Structure (Camb) 12, 1607-1618 (2004).
27. Lescar, J. et al. The fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 105, 137-148 (2001).
28. Choi, H. K. et al. Structural analysis of Sindbis virus capsid mutants involving assembly and catalysis. J. Mol. Biol. 262, 151-167 (1996).
29. Dokland, T. et al. West Nile virus core protein; tetramer structure and ribbon formation. Structure (Camb) 12, 1157-1163 (2004).
30. Konishi, E. & Mason, P. W. Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J. Virol. 67, 1672-1675 (1993).
31. Allison, S. L., Stadler, K., Mandl, C. W., Kunz, C. & Heinz, F. X. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J. Virol. 69 5816-5820 (1995).
32. Lee, E. & Lobigs, M. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J. Virol. 76, 4901-4911 (2002).
33. Hung, S.-L. et al. Analysis of the steps involved in dengue virus entry into host cells. Virology 257, 156-167 (1999).
34. Crill, W. D. & Roehrig, J. T. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75, 7769-7773 (2001).
35. Chiu, M. W. & Yang, Y. L. Blocking the dengue virus 2 infections on BHK-21 cells with purified recombinant dengue virus 2 E protein espressed in Escherichia coli. Biochem. Biophys. Res. Commun. 309, 672-678 (2003).
36. Chen, Y. et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nature Med. 3, 866-871 (1997).
37. Bhardwaj, S., Holbrook, M., Shope, R. E., Barrett, A. D. & Watowich, S. J. Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J. Virol. 75, 4002-4007 (2001).
38. Wu, K. P. et al. Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of thi domain III of the Japanese encephalitis virus envelope protein. J. Biol. Chem. 278, 46007-46013 (2003).
39. Navarro-Sanchez, E. et al. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep. 4, 723-728 (2003).
40. Mukhopadhyay, S., Kim, B. S., Chipman, P. R., Rossmann, M. G. & Kuhn, R. J. Structure of West Nile virus. Science 302, 248 (2003).
41. Chen, Y. C., Wang, S. Y. & King, C. C. Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J. Virol. 73, 2650-2657 (1999).
42. Jindadamrongwech, S., Thepparit, C. & Smith, D. R. Identification of GRP78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch. Virol. 149, 915-927 (2004).
43. Tassaneetrithep, B. et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197, 823-829 (2003).
44. Reyes-del Valle, J. & del Angel, R. M. Isolation of putative dengue virus receptor molecules by affinity chromatography using a recombinant E protein ligand. J. Virol. Methods 116, 95-102 (2004).
45. Yazi Mendoza, M., Salas-Benito, J., Lanz-Mendoza, H., Hernandez-Martinez, S. & del Angel, R. A putative receptor for dengue virus in mosquito tissues: localization of a 45-kDa glycoprotein. Am. J. Trop. Med. Hyg. 67, 76-84 (2002).
46. Salas-Benito, J. S. & del Angel, R. M. Identification of two surface proteins from C6/36 cells that bind dengue type 4 virus. J. Virol. 71, 7246-7252 (1997).
47. Moreno-Altamirano, M. M. B., Sanchez-Garcia, F. J. & Munoz, M. L. Non Fc receptor-mediated infection of human macrophages by dengue virus serotype 2. J. Gen. Virol. 83, 1123-1130 (2002).
48. Ramos-Castaneda, J., Imbert, J. L., Barron, B. L. & Ramos, C. A 65-kDa trypsin-sensible membrane cell protein as a possible receptor for dengue virus in cultured neuroblastoma cells. J. Neurovirol. 3, 435-440 (1997).
49. de Lourdes Munoz, M. et al. Putative dengue virus receptors from mosquito cells. FEMS Microbiol. Lett. 168, 251-258 (1998).
50. Bielefeldt-Ohmann, H. Analysis of antibody-independent binding of dengue viruses and dengue virus envelope protein to human myelomonocytic cells and B lymphocytes. Virus Res. 57, 63-79 (1998).
51. Bielefeldt-Ohmann, H., Meyer, M., Fitzpatrick, D. R. & Mackenzie, J. S. Dengue virus binding to human leukocyte cell lines: receptor usage differs between cell types and virus strains. Virus Res. 73, 81-89 (2001).
52. Wei, H. Y., Jiang, L. F., Fang, D. Y. & Guo, H. Y. Dengue virus type 2 infects human endothelial ceis through binding of the viral envelope glycoprotein to cell surface polypeptides. J. Gen. Virol. 84, 3095-3098 (2003).
53. Hilgard, F. & Stockert, R. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology 32 1069-1077 (2002).
54. Chu, J. J. & Ng, M. L. Characterization of a 105-kDa plasma membrane associated glycoprotein that is involved in West Nile virus binding and infection. Virology 312, 458-469 (2003).
55. Kimura, T., Kimura-Kuroda, J., Nagashima, K. & Yasui, K. Analysis of virus-cell binding characteristics on the determination of Japanese encephalitis virus susceptibility. Arch. Virol. 139, 239-251 (1994).
56. Kopecky, J., Grubhoffer, L., Kovar, V., Jindrak, L. & Vokurkova, D. A putative host cell receptor for tick-borne encephalitis virus identified by anti-idiotypic antibodies and virus affinoblotting. Intervirology 42, 9-16 (1999).
57. Maldov, D. G., Karganova, G. G. & Timofeev, A. V. Tick-borne encephalitis virus interaction with the target cells. Arch. Virol. 127, 321-325 (1992).
58. Martinez-Barragan, J. J. & del Angel, R. M. Identification of a putative coreceptor on Vero cells that participates in dengue 4 virus infection. J. Virol. 75, 7818-7827 (2001).
59. Lin, Y. L. et al. Heparin inhibits dengue-2 virus infection of five human liver cell lines. Antiviral Res. 56, 93-96 (2002).
60. Germi, R. et al. Heparin sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology 292, 162-168 (2002).
61. Su, C. M., Liao, C. L., Lee, Y. L. & Lin, Y. L. Highly sulfated forms of heparin sulfate are involved in Japanese encephalitis virus infection. Virology 286, 206-215 (2001).
62. Lee, E. & Lobigs, M. Substitutions at the putative receptor-binding site of an encephalitic flavivirus after virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J. Virol. 74, 8867-8875 (2000).
63. Mandl, C. W. et al. Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J. Virol. 75, 5627-5637 (2001).
64. Kroschewski, H., Allison, S. L., Heinz, F. X. & Mandl, C. W. Role of heparan sulfate for attachment and entry of tick-borne encephalitis virus. Virology 308, 92-100 (2003).
65. Dimitrov, D. S. Virus entry: molecular mechanisms and biomedical applications. Nature Rev. Microbiol. 2, 109-122 (2004).
66. van der Most, R. G., Corver, J. & Strauss, J. H. Mutagenesis of the RGD motif in the yellow fever virus 17D envelope protein. Virology 265, 83-95 (1999).
67. Allison, S. L., Stiasny, K., Stadler, K., Mandl, C. W. & Heinz, F. X. Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J. Virol. 73 5605-5612 (1999).
68. Stiasny, K., Allison, S. L., Marchler-Bauer, A., Kunz, C. & Heinz, F. X. Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus. J. Virol. 70, 8142-8147 (1996).
69. Stiasny, K., Allison, S. L., Mandl, C. W. & Heinz, F. X. Role of metastability and acidic pH in membrane fusion by tick-borne encephalitis virus. J. Virol. 75, 7392-7398 (2001).
70. Stiasny, K., Allison, S. L., Schalich, J. & Heinz, F. X. Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH. J. Virol. 76, 3784-3790 (2002).
71. Bressanelli, S. et al. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J. 23, 728-738 (2004).
72. Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313-319 (2004).
73. Gibbons, D. L. et al. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. Nature 427, 320-325 (2004).
74. Jones, C. T. et al. Flavivirus capsid is a dimeric α-helical protein. J. Virol. 77, 7143-7149 (2003).
75. Kiermayr, S., Kofler, R. M., Mandl, C. W., Messner, P. & Heinz, F. X. Isolation of capsid protein dimers from the tick-borne encephalitis (TBE) flavivirus and in vitro assembly of capsid-like particles. J. Virol. 78, 8078-8084 (2004).
76. Johnson, J. E. Functional implications of protein-protein interactions in icosahedral viruses. Proc. Natl Acad. Sci. USA 93, 27-33 (1996).
77. Rossmann, M. G. & Johnson, J. E. Icosahedral RNA virus structure. Annu. Rev. Biochem. 58, 533-573 (1989).
78. Kofler, R. M., Heinz, F. X. & Mandl, C. W. Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence. J. Virol. 76 3534-3543 (2002).
79. Kofler, R. M., Leitner, A., O'Riordain, G., Heinz, F. X. & Mandl, C. W. Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein C. J. Virol. 77, 443-451 (2003).
80. Russell, P. K., Brandt, W. E. & Dalrymple, J. in The Togaviruses (ed. Sclhlesinger, R. W.) 503-529 (Academic Press, New York, 1980).
81. Ferlenghi, I. et al. Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol. Cell 7, 593-602 (2001).
82. Allison, S. L. et al. Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virus. J. Virol. 77, 11357-11366 (2003).
83. Konishi, E. et al. Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection. Virology 188, 714-720 (1992).
84. Kuhn, R. J. et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, 717-725 (2002).
85. Zhang, Y. et al. Structures of immature flavivirus particles. EMBO J. 22, 2604-2613 (2003).
86. Caspar, D. L. & Klug, A. Physical principles in the construction of regular viruses. Cold Spring Harb. Symp. Quaunt. Biol. 27, 1-24 (1962).
87. Heinz, F. X. & Allison, S. L. Structures and mechanisms in flavivirus fusion. Adv. Virus Res. 55, 231-269 (2000).
88. Werten, P. J. et al. Progress in the analysis of membrane protein structure and function. FEBS Lett. 529, 65-72 (2002).
89. Cockburn, J. J., Bamford, J. K., Grimes, J. M., Bamford, D. H. & Stuart, D. I. Crystallization of the membrane-containing bacteriophage PRD1 in quartz capillaries by vapour diffusion. Acta Crystallogr. D Biol. Crystallogr. 59, 538-540 (2003).
90. Op De Beeck, A. et al. Role of the transmembrane domains of prM and E proteins in the formation of yellow fever virus envelope. J. Virol. 77, 813-820 (2003).
91. Pletnev, S. V. et al. Locations of carbohydrate sites on α-virus glycoproteins show that E1 forms an icosahedral scaffold. Cell 105, 127-136 (2001).
92. Wilson, I. A., Skehel, J. J. & Wiley, D. C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289, 366-373 (1981).
93. Skehel, J. J. & Wiley, D. C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69, 531-569 (2000).
94. Weissenhorn, W. et al. Structural basis for membrane fusion by enveloped viruses. Mol. Membr. Biol. 16, 3-9 (1999).